Bristol Myers Squibb – The US pharmaceutical giant upgrades drug research with NVIDIA's latest AI supercomputer!
Reading Time: 3 minutes
Bristol Myers Squibb is the first life sciences company to purchase an Nvidia supercomputer of the new Vera Rubin generation for AI-supported drug research. The company is already shortening development time by 20–30%, and potentially up to 50% in the future. According to the head of research, a sickle cell drug would never have been discovered without AI. A Supercomputer for Drug Discovery Bristol Myers Squibb is relying on immense computing power in the fight against tomorrow's diseases: The US pharmaceutical company is purchasing the latest...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

